Multi-centre, randomised, open label pragmatic trial to compare the effectiveness and safety of interferon beta-1a (IFN-beta-1a) weekly i.m. and glatiramer-acetate (GA) in paediatric patients affected by multiple sclerosis.
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Sep 2018 New trial record